SCHEMBL8864629

SCHEMBL8864629

CCN(C(=O)C1(c2ccc(C)c(N=S(=O)=O)c2)CC1)C(=S)NC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8864646 0.92 — —
SCHEMBL8864394 0.89 — —
SCHEMBL8864948 0.88 OPRM1 (0.31) —
SCHEMBL8865054 0.88 OPRM1 (0.31) —
SCHEMBL8864655 0.88 OPRM1 (0.31) —
SCHEMBL8864568 0.87 LMNA (0.34) —
SCHEMBL8864570 0.86 AKR1B10 (0.30) —
SCHEMBL8864339 0.85 — —
SCHEMBL8864662 0.84 — —
SCHEMBL8864440 0.83 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5633239-A CARDIOVASCULAR DISORDERS; HYPOGLYCEMIC AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1997-05-27 — — US disclosed
Send feedback